Skip to main content

Advertisement

SpringerLink
Log in

The role of preoperative chemotherapy for esophageal cancer: when is surgery alone feasible?

  • Viewpoint
  • Published:

From Nature Clinical Practice Oncology

View current issue Sign up to alerts

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Kelsen D et al. (1998) Chemotherapy followed by surgery compared with surgery alone for localized esophageal cancer. N Engl J Med 339: 1979–1984

    Article  CAS  Google Scholar 

  2. Brenner B et al. (2004) Treatment of localized esophageal cancer. Semin Oncol 31: 554–565

    Article  Google Scholar 

  3. Medical Research Council Oesophageal Cancer Working Group (2002) Surgical resection with or without preoperative chemotherapy in oesophageal cancer: a randomised controlled trial. Lancet 359: 1727–1733

  4. Malthaner R and Fenlon D (2003) Preoperative chemotherapy for resectable thoracic esophageal cancer. Cochrane Database Syst Rev CD001556

  5. Kaklamanos IG et al. (2003) Neoadjuvant treatment for resectable cancer of the esophagus and the gastroesophageal junction: a meta-analysis of randomized clinical trials. Ann Surg Oncol 10: 754–761

    Article  Google Scholar 

  6. Urschel JD et al. (2002) A meta-analysis of randomized controlled trials that compared neoadjuvant chemotherapy and surgery to surgery alone for resectable esophageal cancer. Am J Surg 183: 274–279

    Article  Google Scholar 

  7. Allum W et al. (2003) Perioperative chemotherapy in operable gastric and lower oesophageal cancer: A randomised, controlled trial (the MAGIC trial, ISRCTN 93793971). [abstract] Proc Am Soc Clin Oncol 22: a998

    Google Scholar 

  8. Sumpter K et al. (2003) Randomised, multicentre phase III study comparing capecitabine with fluorouracil and oxaliplatin with cisplatin in patients with advanced oesophagogastric cancer: confirmation of dose escalation. [abstract] Proc Am Soc Clin Oncol 22: a1031

    Google Scholar 

  9. Muro K et al. (2004) A phase II study of single-agent docetaxel in patients with metastatic esophageal cancer. Ann Oncol 15: 955–959

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. medical oncologist at the Royal Marsden Hospital, London, UK

    Geoff Chong

  2. Professor and Head of the Gastrointestinal Cancer Unit at the Royal Marsden Hospital, London, UK

    David Cunningham

Authors
  1. Geoff Chong
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. David Cunningham
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to David Cunningham.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Chong, G., Cunningham, D. The role of preoperative chemotherapy for esophageal cancer: when is surgery alone feasible?. Nat Rev Clin Oncol 2, 172–173 (2005). https://doi.org/10.1038/ncponc0126

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ncponc0126

  • Springer Nature Limited

Search

Navigation